0000899243-20-032672.txt : 20201203 0000899243-20-032672.hdr.sgml : 20201203 20201203162620 ACCESSION NUMBER: 0000899243-20-032672 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201201 FILED AS OF DATE: 20201203 DATE AS OF CHANGE: 20201203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daniel Jennifer CENTRAL INDEX KEY: 0001797725 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 201367219 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-01 0 0001490978 Schrodinger, Inc. SDGR 0001797725 Daniel Jennifer C/O SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036 0 1 0 0 See Remarks Common Stock 2020-12-01 4 M 0 1923 4.34 A 8611 D Common Stock 2020-12-01 4 M 0 10032 3.07 A 18643 D Common Stock 2020-12-01 4 S 0 3605 67.9598 D 15038 D Common Stock 2020-12-01 4 S 0 4226 68.7499 D 10812 D Common Stock 2020-12-01 4 S 0 3324 70.0706 D 7488 D Common Stock 2020-12-01 4 S 0 800 70.6811 D 6688 D Common Stock 2020-12-02 4 M 0 1923 4.34 D 8611 D Common Stock 2020-12-02 4 M 0 10033 3.07 D 18644 D Common Stock 2020-12-02 4 S 0 1500 64.5993 D 17144 D Common Stock 2020-12-02 4 S 0 8556 65.94 D 8588 D Common Stock 2020-12-02 4 S 0 1900 66.4258 D 6688 D Stock Option (right to buy) 4.34 2020-12-01 4 M 0 1923 0.00 D 2028-11-29 Common Stock 1923 18142 D Stock Option (right to buy) 3.07 2020-12-01 4 M 0 10032 0.00 D 2027-04-07 Common Stock 10032 56854 D Stock Option (right to buy) 4.34 2020-12-02 4 M 0 1923 0.00 D 2028-11-29 Common Stock 1923 16219 D Stock Option (right to buy) 3.07 2020-12-02 4 M 0 10033 0.00 D 2027-04-07 Common Stock 10033 46821 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.36 to $68.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.37 to $69.17, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.40 to $70.30, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.43 to $70.94, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.21 to $64.96, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.29 to $66.28, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.29 to $66.83, inclusive. This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022. This option was granted on April 7, 2017. The shares underlying the option are scheduled to vest in equal yearly installments from February 22, 2017 through February 22, 2021. Senior Vice President and Chief Human Resources Officer Exhibit Index: 24.1 Power of Attorney /s/ Donald Shum, as attorney-in-fact for Jennifer Daniel 2020-12-03 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT

                                                                    Exhibit 24.1

                           LIMITED POWER OF ATTORNEY
                      FOR SECTION 16 REPORTING OBLIGATIONS

     Know all by these presents, that the undersigned hereby makes, constitutes
and appoints each of Joel Lebowitz, Yvonne Tran, Jenny Herman, Donald Shum and
Jason Schmidt signing singly and each acting individually, as the undersigned's
true and lawful attorney-in-fact with full power and authority as hereinafter
described to:

    (1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer of Schrodinger, Inc. (the "Company"), Forms 3, 4, and 5
(including any amendments thereto) in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended, and the rules thereunder (the
"Exchange Act");

     (2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to prepare, complete and execute any such
Form 3, 4, or 5, prepare, complete and execute any amendment or amendments
thereto, and timely deliver and file such form with the United States Securities
and Exchange Commission (the "SEC") and any stock exchange or similar authority,
including without limitation the filing of a Form ID, Update Passphrase, or any
other application materials to enable the undersigned to gain or maintain access
to the Electronic Data Gathering, Analysis and Retrieval system of the SEC;

     (3) seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information regarding transactions in the Company's
securities from any third party, including brokers, employee benefit plan
administrators and trustees, and the undersigned hereby authorizes any such
person to release any such information to such attorney-in-fact and approves and
ratifies any such release of information; and

     (4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

     The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming nor
relieving, nor is the Company assuming nor relieving, any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act.  The undersigned
acknowledges that neither the Company nor the foregoing attorneys-in-fact assume
(i) any liability for the undersigned's responsibility to comply with the
requirements of the Exchange Act, (ii) any liability of the undersigned for any
failure to comply with such requirements, or (iii) any obligation or liability
of the undersigned for profit disgorgement under Section 16(b) of the Exchange
Act.

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 2nd day of December, 2020.

                                            /s/ Jennifer Daniel
                                            ------------------------------------
                                            Name:  Jennifer Daniel